NfL Shows Potential as CMT Biomarker, But More Work Needed

NfL Shows Potential as CMT Biomarker, But More Work Needed

283289

NfL Shows Potential as CMT Biomarker, But More Work Needed

Blood plasma levels of the protein neurofilament light chain (NfL) are elevated in Charcot-Marie-Tooth disease (CMT) patients and correlate somewhat with disease severity, a recent study reports. These findings suggest that the protein may serve as a clinical biomarker for identifying CMT and tracking disease progression, but more work in validating its use is necessary. The study, “Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease,” appeared in the European Journal of Neurology.  CMT,…

You must be logged in to read/download the full post.